Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba

*Department of Internal Medicine, Rady Faculty of Health Sciences

†Department of Internal Medicine, Section of Medical Oncology and Hematology, Rady Faculty of Health Sciences, University of Manitoba

‡Paul Albrechtsen Research Institute CancerCare Manitoba

§George and Fay Yee Centre for Healthcare Innovation, Winnipeg, MB, Canada

C.A.K.: declares research funding from Celgene Inc & an honorarium for educational content from Amgen, but both of these are outside of this work. There was no specific funding for this work.

C.A.K.: declares research funding from Celgene Inc and an honorarium for educational content from Amgen, both outside the submitted work. For the remaining authors none were declared.

Correspondence: Christina A. Kim, MD, L1-101-409 Tache Avenue, Winnipeg, MB R2H 2A6, Canada. E-mail: [email protected].

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, www.amjclinicaloncology.com.

留言 (0)

沒有登入
gif